These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
443 related articles for article (PubMed ID: 34170581)
1. Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer. Song R; Li T; Ye J; Sun F; Hou B; Saeed M; Gao J; Wang Y; Zhu Q; Xu Z; Yu H Adv Mater; 2021 Aug; 33(31):e2101155. PubMed ID: 34170581 [TBL] [Abstract][Full Text] [Related]
2. Acidity-activatable dynamic hybrid nanoplatforms derived from extracellular vesicles of M1 macrophages enhance cancer immunotherapy through synergistic triple immunotherapy. Guo Y; Lv T; Li Z; Wei X; Yang C; Li W; Hou X; Wang Z; Qian R J Nanobiotechnology; 2024 Jul; 22(1):430. PubMed ID: 39033108 [TBL] [Abstract][Full Text] [Related]
3. Redox Dyshomeostasis with Dual Stimuli-Activatable Dihydroartemisinin Nanoparticles to Potentiate Ferroptotic Therapy of Pancreatic Cancer. Wang Y; Chen F; Zhou H; Huang L; Ye J; Liu X; Sheng W; Gao W; Yu H; Wang F Small Methods; 2023 May; 7(5):e2200888. PubMed ID: 36446643 [TBL] [Abstract][Full Text] [Related]
4. A Triple-Responsive Polymeric Prodrug Nanoplatform with Extracellular ROS Consumption and Intracellular H Li Y; Cao Y; Ma K; Ma R; Zhang M; Guo Y; Song H; Sun N; Zhang Z; Yang W Adv Healthc Mater; 2024 Jun; 13(16):e2303568. PubMed ID: 38319010 [TBL] [Abstract][Full Text] [Related]
5. Photo-Enhanced Synergistic Induction of Ferroptosis for Anti-Cancer Immunotherapy. Zhou Y; Chen K; Lin WK; Liu J; Kang W; Zhang Y; Yang R; Jin L; Cheng Y; Xu A; Wang W Adv Healthc Mater; 2023 Oct; 12(27):e2300994. PubMed ID: 37432874 [TBL] [Abstract][Full Text] [Related]
6. Platelet Membrane-Camouflaged Magnetic Nanoparticles for Ferroptosis-Enhanced Cancer Immunotherapy. Jiang Q; Wang K; Zhang X; Ouyang B; Liu H; Pang Z; Yang W Small; 2020 Jun; 16(22):e2001704. PubMed ID: 32338436 [TBL] [Abstract][Full Text] [Related]
7. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy. Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771 [TBL] [Abstract][Full Text] [Related]
8. Application of singlet oxygen-activatable nanocarriers to boost X-ray-induced photodynamic therapy and cascaded ferroptosis for breast cancer treatment. Zhang B; Liu H; Wang Y; Zhang Y; Cheng J J Mater Chem B; 2023 Oct; 11(40):9685-9696. PubMed ID: 37789698 [TBL] [Abstract][Full Text] [Related]
9. Sequentially Activatable Polypeptide Nanoparticles for Combinatory Photodynamic Chemotherapy of Breast Cancer. Zhang H; Pan J; Wang T; Lai Y; Liu X; Chen F; Xu L; Qu X; Hu X; Yu H ACS Appl Mater Interfaces; 2022 Sep; 14(35):39787-39798. PubMed ID: 36001127 [TBL] [Abstract][Full Text] [Related]
10. Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy. Wang D; Wang T; Liu J; Yu H; Jiao S; Feng B; Zhou F; Fu Y; Yin Q; Zhang P; Zhang Z; Zhou Z; Li Y Nano Lett; 2016 Sep; 16(9):5503-13. PubMed ID: 27525587 [TBL] [Abstract][Full Text] [Related]
11. Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis. Guo W; Wu Z; Chen J; Guo S; You W; Wang S; Ma J; Wang H; Wang X; Wang H; Ma J; Yang Y; Tian Y; Shi Q; Gao T; Yi X; Li C J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35738798 [TBL] [Abstract][Full Text] [Related]
12. Transformable Supramolecular Self-Assembled Peptides for Cascade Self-Enhanced Ferroptosis Primed Cancer Immunotherapy. Wang H; Jiao D; Feng D; Liu Q; Huang Y; Hou J; Ding D; Zhang W Adv Mater; 2024 May; 36(21):e2311733. PubMed ID: 38339920 [TBL] [Abstract][Full Text] [Related]
13. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. Efimova I; Catanzaro E; Van der Meeren L; Turubanova VD; Hammad H; Mishchenko TA; Vedunova MV; Fimognari C; Bachert C; Coppieters F; Lefever S; Skirtach AG; Krysko O; Krysko DV J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188036 [TBL] [Abstract][Full Text] [Related]
14. Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor Immunotherapy. Lei H; Li Q; Pei Z; Liu L; Yang N; Cheng L Small; 2023 Nov; 19(45):e2303438. PubMed ID: 37420331 [TBL] [Abstract][Full Text] [Related]
15. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma. Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186 [TBL] [Abstract][Full Text] [Related]
16. Boosting the synergism between cancer ferroptosis and immunotherapy via targeted stimuli-responsive liposomes. Gao Z; Zhang J; Hou Y; Lu J; Liang J; Gao Y; Li B; Gao S; Zhao Y; Gao M; Chen J Biomaterials; 2024 Mar; 305():122442. PubMed ID: 38142469 [TBL] [Abstract][Full Text] [Related]
17. Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy. Ye J; Hou B; Chen F; Zhang S; Xiong M; Li T; Xu Y; Xu Z; Yu H Acta Pharm Sin B; 2022 Jun; 12(6):2695-2709. PubMed ID: 35755274 [TBL] [Abstract][Full Text] [Related]
18. Renal Clearable Ultrasmall Single-Crystal Fe Nanoparticles for Highly Selective and Effective Ferroptosis Therapy and Immunotherapy. Liang H; Wu X; Zhao G; Feng K; Ni K; Sun X J Am Chem Soc; 2021 Sep; 143(38):15812-15823. PubMed ID: 34473493 [TBL] [Abstract][Full Text] [Related]
19. Dendrimer/metal-phenolic nanocomplexes encapsulating CuO Huang H; Guo H; Liu J; Ni C; Xia L; Cao X; Xia J; Shi X; Guo R Acta Biomater; 2024 Jul; 183():252-263. PubMed ID: 38801869 [TBL] [Abstract][Full Text] [Related]
20. Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy. Li Y; Liu J; Chen Y; Weichselbaum RR; Lin W Adv Sci (Weinh); 2024 Jun; 11(23):e2310309. PubMed ID: 38477411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]